Gengfu Xiao

Gengfu Xiao publications per year

Gengfu Xiao publication distribution in Microbiology in 2027

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2027. The highlighted bar marks where Gengfu Xiao sits on this spectrum.

Gengfu Xiao D-index placement in Microbiology in 2027

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2027. The highlighted bar marks where Gengfu Xiao sits on this spectrum.

Best Publications

• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

  Manli Wang;Ruiyuan Cao;Leike Zhang;Xinglou Yang

  7990
  Citations

• Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

  Zhenming Jin;Zhenming Jin;Xiaoyu Du;Yechun Xu;Yongqiang Deng

  4716
  Citations

• Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.

  Wei Zhang;Rong-Hui Du;Bei Li;Xiao-Shuang Zheng

  2043
  Citations

• Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.

  Wenhao Dai;Wenhao Dai;Bing Zhang;Xia Ming Jiang;Haixia Su

  1446
  Citations

• Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

  Shuwen Liu;Gengfu Xiao;Yibang Chen;Yuxian He

  685
  Citations

• Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin

  Peng Zhou;Xing-Lou Yang;Xian-Guang Wang;Ben Hu

  489
  Citations

• Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.

  Zhenming Jin;Zhenming Jin;Yao Zhao;Yuan Sun;Bing Zhang

  417
  Citations

• Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.

  Unknown

  178
  Citations

• SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.

  Bingqing Xia;Xurui Shen;Yang He;Xiaoyan Pan

  173
  Citations

• Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin.

  Wanchao Yin;Xiaodong Luan;Xiaodong Luan;Zhihai Li;Ziwei Zhou

  163
  Citations

• Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection.

  Shaobo Wang;Yang Liu;Jiao Guo;Peilin Wang

  161
  Citations

• High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.

  Yao Zhao;Xiaoyu Du;Yinkai Duan;Xiaoyan Pan

  151
  Citations

• Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality

  Hao Li;Lei-Ke Zhang;Shu-Fen Li;Shao-Fei Zhang

  147
  Citations

• Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients.

  Li Kun Zhou;Li Kun Zhou;Zhen Zhou;Xia Ming Jiang;Yishan Zheng

  146
  Citations

• Structure of Mpro from COVID-19 virus and discovery of its inhibitors

  Z. Jin;Z. Jin;X. Du;Y. Xu;Y. Deng

  145
  Citations

• Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.

  Jieqing Zhu;Gengfu Xiao;Yanhui Xu;Fang Yuan

  143
  Citations

• SFTSV Infection Induces BAK/BAX-Dependent Mitochondrial DNA Release to Trigger NLRP3 Inflammasome Activation

  Shufen Li;Hao Li;Yu-Lan Zhang;Qi-Lin Xin

  137
  Citations

• Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2.

  Yuanchao Xie;Wanchao Yin;Yumin Zhang;Weijuan Shang

  119
  Citations

• SARS coronavirus induces apoptosis in Vero E6 cells.

  Huimin Yan;Gengfu Xiao;Jiamin Zhang;Yuanyang Hu

  117
  Citations

• Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19

  Zhenming Jin;Zhenming Jin;Xiaoyu Du;Yechun Xu;Yongqiang Deng

  113
  Citations